Science Publishing Group

Nerd Street Gamers Partners with CSL Esports and Albright College to Develop State of the Art Collegiate Esports Facility

Retrieved on: 
Thursday, January 13, 2022
LinkedIn, Albright, Nerd, League, Science, Athlete, Sport, Call of Duty, Localhost, Industry, Curriculum, CSL, Business development, National Association, Technology, Call, Personal computer, Adult, NHL, Student, NACE, Five Below, Rocket League, Marketing, CS, Partnership, N3RD Street, National Association of Collegiate Esports, NCAA, Science Publishing Group, Founders Fund, Esports, Facebook, Program, Education, League of Legends, Video, Mathematical Sciences Research Institute, Investment, University, Wall Street, Comcast Spectacor, CEO, Learning, School, Recreational therapy, Recreation, NBA, MLB, Albright College, Twitter, Video game, Tutoring

PHILADELPHIA, Jan. 13, 2022 /PRNewswire-PRWeb/ -- Nerd Street Gamers, the national esports infrastructure company, announced today its partnership with CSL Esports, a Playfly Sports Company, and Albright College to create a state of the art collegiate esports facility.

Key Points: 
  • PHILADELPHIA, Jan. 13, 2022 /PRNewswire-PRWeb/ -- Nerd Street Gamers, the national esports infrastructure company, announced today its partnership with CSL Esports, a Playfly Sports Company, and Albright College to create a state of the art collegiate esports facility.
  • In partnership with CSL Esports, Nerd Street brings that opportunity and accessibility to Albright College allowing the school to set the standard for the future of collegiate esports facilities.
  • Nerd Street and CSL Esports continue their partnership after successfully launching the National Association of Collegiate Esports (NACE) Starleague, the largest collegiate esports league in North America.
  • http://www.cslesports.com
    Nerd Street Gamers (Nerd Street) is a national network of esports facilities and events dedicated to powering competitive opportunities for gamers.

Aberrant Splicing of CD22 in Acute Lymphoblastic Leukemia Underlies Resistance to Immunotherapy

Retrieved on: 
Tuesday, January 4, 2022
CHOP, RNA transfection, University, Pediatrics, Children's Hospital, Association, Lists of World Heritage Sites, Childhood leukemia, Failure, Health, Doctor of Philosophy, Patient, Pathology, Immune system, Hospital, Exon, Oncology, Cancer, RNA, Children's Hospital of Philadelphia, Science Publishing Group, American Association for Cancer Research, CD19, Disease, Observation, Lymphatic system, B-ALL, American Association, Division, Biomarker, Inotuzumab ozogamicin, Antibody, Diagnosis, Population, Leukemia, Medical laboratory, Canadian Aviation Regulations, Children's Oncology Group, DOI, Immunotherapy, CAR, Associate, Program, ALL, Alternative splicing, Philadelphia, Vaccine, Child, MD, CD22

One way to achieve this is by paying close attention to aberrant RNA splicing events, like those described in our study."

Key Points: 
  • One way to achieve this is by paying close attention to aberrant RNA splicing events, like those described in our study."
  • Adoptive immunotherapy, in which a patient's own immune system is used to kill cancer cells, has been a breakthrough in the treatment of B-ALL.
  • Although earlier studies had shown that CD22 undergoes alternative splicing, the role of these CD22 isoforms in the context of immunotherapy had not been characterized.
  • In one case, it was the only CD22 isoform, and predictably that patient did not respond to treatment with inotuzumab.

Kymera Therapeutics Presents Positive Preclinical Data on Selective STAT3 Degraders for Hematological and Solid Tumor Malignancies at 63rd American Society of Hematology (ASH) Annual Meeting

Retrieved on: 
Monday, December 13, 2021
Therapy, Pathology, Doctor of Philosophy, Science Publishing Group, NASDAQ, Boston Business Journal, Risk, Neoplasm, PTCL, Lymphoma, Boston, Cell death, Treatment, ALCL, LinkedIn, Lymphoid neoplasms with plasmablastic differentiation, NK, Growth, Tumor microenvironment, Biomarker, U.S. Securities and Exchange Commission, Safety, Security (finance), MD, GLOBE, ASH, Society, Experiment, Compte rendu, PDTX, Drug resistance, Nasdaq, Peripheral T-cell lymphoma, Science, COVID-19, Weill Cornell Medicine, GA, CEO, Biotechnology, STAT3, Twitter, Large-cell lung carcinoma, Pharmacology, Hematology, B-cell lymphoma, Private Securities Litigation Reform Act, Colorectal cancer, Entrepreneurship, Lymphatic system, Patient, Medical laboratory, Growth arrest lines, Medical imaging, Fine chemical, Vaccine, Pharmaceutical industry, Black Majesty

WATERTOWN, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel, small molecule protein degrader therapeutics, today announced the company presented new preclinical data for its STAT3 degraders, including its first-in-class KT-333 STAT3 degrader, at the virtual 63rd American Society of Hematology (ASH) Annual Meeting taking place from December 11 – 14, 2021 in Atlanta, GA and virtually.

Key Points: 
  • This resulted in eradication of ALK+ ALCL tumor xenografts with weekly or every other week dosing associated with >90% STAT3 knockdown in tumors and modulation of STAT3-dependent signaling.
  • The second presentation, Selective STAT3 Degraders Dissect Peripheral T-Cell Lymphomas Vulnerabilities Empowering Personalized Regimens highlights results from a research collaboration with Georgio Inghirami, MD, Weill Cornell Medical College.
  • STAT3 degraders were also shown to synergize with other targeted agents, such as venetoclax, in various peripheral T-cell lymphoma (PTCL) PDTX models.
  • No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.

University of Louisville Health Adopts Paige AI-enabled Cancer Detection Software for Enhanced Cancer Detection

Retrieved on: 
Wednesday, December 15, 2021
Oncology, Health, FDA, Medical Devices, Technology, Software, Biotechnology, Hospital, Marie Cassidy, FDA, Pathology, European Economic Area, Urban economics, Algorithm, University of Louisville, Health, University of Louisville School of Medicine, Science Publishing Group, UofL Health, IVD, Cancer, AI, Oncology, Research, Anatomical pathology, MSK, Patient, Memorial Sloan Kettering Cancer Center, Medical laboratory, Tissue, Laboratory, Efficiency, Workflow, University, UofL, Assistant, Technology, Association Residence Nursing Home, Medical device, Medical imaging

Paige , the global leader in AI-based diagnostic software in pathology, today announced that University of Louisville (UofL) Health, a leading academic health system based in Louisville, Kentucky, has deployed a full suite of Paige AI-enabled digital pathology software to improve diagnostic confidence, efficiency, and patient care during routine cancer diagnosis.

Key Points: 
  • Paige , the global leader in AI-based diagnostic software in pathology, today announced that University of Louisville (UofL) Health, a leading academic health system based in Louisville, Kentucky, has deployed a full suite of Paige AI-enabled digital pathology software to improve diagnostic confidence, efficiency, and patient care during routine cancer diagnosis.
  • UofL Health will also deploy Paiges FullFocus as their digital pathology case management tool and digital pathology image viewer, and Paige Breast to elevate pathologists ability to diagnose cancer.
  • With cancer cases on the rise globally, AI technologies have the potential to help pathologists work more confidently and efficiently.
  • Paige is the first company to receive FDA approval for an AI-based digital pathology product.

Rhonda Barnet Appointed to the Board of the Electrical Safety Authority Representing Consumer Interests

Retrieved on: 
Friday, December 10, 2021
Technology, Board of directors, Connecticut Business Hall of Fame, CME, STEM, Association, Euro NCAP, Government, Electricity Act, 2007 College Football Hall of Fame inductees, Trent University, Woman, Electricity, Government of Ontario, The Electricity Act, 2003, Safety, National Electrical Contractors Association, Policy, ESG, CFO, Science Publishing Group, Engineering, COO, Board, National Board of Boiler and Pressure Vessel Inspectors, Science, History, Master electrician, ESA, Computer science, National Information and Communication Technology Awards, Management

MISSISSAUGA, ON, Dec. 10, 2021 /CNW/ -The Electrical Safety Authority's (ESA's) Board of Directors is pleased to announce that Rhonda Barnet has been elected to the Board.

Key Points: 
  • MISSISSAUGA, ON, Dec. 10, 2021 /CNW/ -The Electrical Safety Authority's (ESA's) Board of Directors is pleased to announce that Rhonda Barnet has been elected to the Board.
  • "I am delighted to welcome Rhonda to the ESA Board representing consumer interests as an experienced executive and a powerful and influential champion for the sectors, causes and people she serves," said Annette Bergeron, Chair of the Board, Electrical Safety Authority.
  • The Electrical Safety Authority (ESA) is an administrative authority acting on behalf of the Government of Ontario with specific responsibilities under the Electricity Act and the Safety and Consumer Statutes Administration Act.
  • As part of its mandate, ESA is responsible for administering regulation in four key areas: the Ontario Electrical Safety Code; licensing of Electrical Contractors and Master Electricians; electrical distribution safety; and electrical product safety.

Retired U.S. Navy Vice Admiral and PayPal Executive Latest to Join Alliance for Decision Education Board

Retrieved on: 
Wednesday, November 10, 2021
Cleveland Browns, Information warfare, University of Finance and Administration, Harvard University, MIT Sloan School of Management, PayPal, MIT, Indianapolis, LSU Football Operations Center, Government, Student, General manager, Education, 1972 Philadelphia Eagles season, CEO, MBA, Science Publishing Group, United States Navy, Alliance, Administration, Mathematics, Gambling in Thailand, Director of Naval Intelligence, Board, Bain & Company, Philadelphia Eagles, GLOBE, Company, Aswath Damodaran, Stanford University, Awareness, Indianapolis Colts, Parent, Navy, School, Bain, Capital One, Commander, Name, California Institute of Technology, Computational mathematics, Yale University, Management, The Walt Disney Company, Medicine

PHILADELPHIA, Nov. 10, 2021 (GLOBE NEWSWIRE) -- The Alliance for Decision Education has added a retired U.S. Navy Vice Admiral and a PayPal Executive to its list of distinguished board members calling for decision-making skills to be incorporated into school curriculums.

Key Points: 
  • PHILADELPHIA, Nov. 10, 2021 (GLOBE NEWSWIRE) -- The Alliance for Decision Education has added a retired U.S. Navy Vice Admiral and a PayPal Executive to its list of distinguished board members calling for decision-making skills to be incorporated into school curriculums.
  • Retired Navy Vice Admiral Jan Elizabeth Tighe joined the Alliance Board along with Michelle Ton, Head of Sales Decision Science at PayPal and an expert in quantitative analytics.
  • Her rank of Vice Admiral is one of the two highest ranks offered by the Navy.
  • The Alliance for Decision Education is a national non-profit leading the growing national call to have Decision Education taught in schools across the country by 2030.

Kymera Therapeutics to Present New Preclinical Data on STAT3 Degraders at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting and the 63rd American Society of Hematology (ASH) Annual Meeting

Retrieved on: 
Thursday, November 4, 2021
Janus, Safety, Fibrosis, Science, Medical laboratory, Annual general meeting, MD, Hall, GA, Biotechnology, Science Publishing Group, LinkedIn, Experiment, Pharmacology, TPD, Immunotherapy, Pathology, Boston Business Journal, Twitter, Security (finance), U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, NASDAQ, Society, Lymphatic system, Boston, Lymphoid neoplasms with plasmablastic differentiation, ASH, Weill Cornell Medicine, Risk, Degenerative disease, Drug resistance, Annual report, Company, COVID-19, MidOcean Partners, Program, Nasdaq, Therapy, GLOBE, SITC, Tumor microenvironment, STAT3, Fine chemical, Pharmaceutical industry

Kymera is developing selective STAT3 degraders for the treatment of hematological malignancies and solid tumors, as well as autoimmune diseases and fibrosis.

Key Points: 
  • Kymera is developing selective STAT3 degraders for the treatment of hematological malignancies and solid tumors, as well as autoimmune diseases and fibrosis.
  • Long considered an undruggable target, STAT3 hyperactivation is prominent in numerous liquid and solid tumors.
  • Kymera Therapeutics explicitly disclaims any obligation to update any forward-looking statements.
  • No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.

Babcock & Wilcox Signs Exclusive Global Licensing Agreement with Ohio State Innovation Foundation for Innovative Chemical Looping Technology for Decarbonization and Hydrogen Production, Further Enhancing B&W’s BrightLoop™ Offering

Retrieved on: 
Tuesday, November 2, 2021
Hardware, Oil, Gas, Chemicals, Plastics, Coal, Alternative Energy, Energy, Manufacturing, Technology, University, Education, Environment, Science, Software, Research, Utilities, Engineering, Carbon, B&W, BW, Research, Technology, LinkedIn, Steam, Annual report, Partnership, Cobalt, Security (finance), CO2, Electric Bond and Share Company v. Securities and Exchange Commission, Hydrogen, NYSE, Copper, Form 10-K, Babcock & Wilcox, Science Publishing Group, Global Engineering Education, Coal, Ohio State University, Nickel, Steel, Risk, Natural gas

B&W and The Ohio State University jointly researched, developed and demonstrated the technology, which B&W offers under the BrightLoop name as part of its innovative ClimateBright suite of decarbonization and hydrogen production technologies.

Key Points: 
  • B&W and The Ohio State University jointly researched, developed and demonstrated the technology, which B&W offers under the BrightLoop name as part of its innovative ClimateBright suite of decarbonization and hydrogen production technologies.
  • B&W and Ohio State researchers have successfully demonstrated production of hydrogen from syngas at the U.S National Carbon Capture Center.
  • B&Ws BrightLoop process is a game-changing solution for clean energy production with near zero carbon emissions, said Brandy Johnson, B&W Vice President Global Engineering.
  • The key to its success is the Ohio State exclusive development of the patented oxygen carrier and the moving bed reduction platform, Fan said.

David and Sharon Johnston Named Honorary Patrons of Homes For Heroes Foundation

Retrieved on: 
Thursday, October 7, 2021
Order of Canada, Military personnel, Mental health, Rideau Hall Foundation, Hockey, Friends, College, Reconciliation, Truth and Reconciliation Commission (South Africa), Regal, RHF, Canadian Association of University Teachers, The Royal Canadian Regiment, Program, GLOBE, Companion, Occupational therapy, Science Publishing Group, Matron, Job, Aichi Medical College for Physical and Occupational Therapy, University, The Right Honourable, Rehabilitation, Little Heroes Foundation, Veteran, Navy, Embarrassment, Toronto, CEO, McGill University, Eye, Homes for Heroes Act of 2013, Association, Principal, Truth, Science, Nightclub, Medicine, Residential care

CALGARY, Alberta, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Homes For Heroes Foundation (H4HF)is extremely pleased to announce that Mr. David Johnston CC and Mrs. Sharon Johnston CC have become the charitys first Honorary Patrons.

Key Points: 
  • CALGARY, Alberta, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Homes For Heroes Foundation (H4HF)is extremely pleased to announce that Mr. David Johnston CC and Mrs. Sharon Johnston CC have become the charitys first Honorary Patrons.
  • Joining Homes For Heroes Foundation as Patrons continues the Johnsons legacy of support to Canada.
  • As a national charity, Homes For Heroes Foundation provides a caring and comprehensive solution to homelessness among Canadas Veterans.
  • Noted Mr. Johnston, What caught our eye is the fact that Homes For Heroes Foundation has developed such an innovative and successful approach to helping our Veterans.

No7 Beauty Company Launches Pure Retinol Collection – Effective Skincare Formulated to Be Gentler for Everyday Use

Retrieved on: 
Tuesday, October 5, 2021
Cosmetics, Retail, Other Communications, Other Health, Pharmaceutical, Communications, Other Consumer, Women, Convenience Store, Luxury, Supermarket, Specialty, Consumer, Health, Fashion, Cream, Walgreens Boots Alliance, Research, Provitamin, Science, Ceramide, Eyes Cream, Certification, MD, Pigment, Consultant, Woman, FAAD, Technology, Gold, Shea butter, Color, Skin, Science Publishing Group, Cosmetics

The Pure Retinol line is launching in conjunction with No7 Beauty Companys campaign We See You, a new campaign from No7 that shines a spotlight on the skincare needs of real women especially those who have historically felt less represented in the beauty industry.

Key Points: 
  • The Pure Retinol line is launching in conjunction with No7 Beauty Companys campaign We See You, a new campaign from No7 that shines a spotlight on the skincare needs of real women especially those who have historically felt less represented in the beauty industry.
  • No7 Pure Retinol Night Cream contains pure retinol, a gold standard ingredient an advanced collagen peptide-based technology providing skin restorative benefits and moisture-rich shea butter to hydrate the skin.
  • No7 Pure Retinol Eye Cream is infused with retinol and collagen peptide-based technology found in the night cream and Provitamin B that attracts and holds moisture.
  • The Pure Retinol collection has been developed in response to womens demand for gentle and effective products.